In an 87-year-old man taking spironolactone, betahistine (Betaserc), and apixaban, what is the differential diagnosis and recommended work‑up for sudden dizziness, eructation, flatulence, and epigastric irritation?

Immediate Evaluation for Electrolyte Disturbance and Cardiac Causes

In an 87-year-old taking spironolactone (not "silosin"), betahistine, and apixaban presenting with sudden dizziness, burping, gas, and epigastric irritation, immediately check serum potassium, renal function, and obtain an ECG to rule out hyperkalemia-induced arrhythmia, as spironolactone carries significant risk of life-threatening hyperkalemia in elderly patients, especially with renal dysfunction.

Critical Safety Concern: Spironolactone in the Elderly

The most urgent consideration is hyperkalemia from spironolactone, which can present with dizziness and gastrointestinal symptoms. In elderly patients, hyperkalemia risk is substantially elevated and can be fatal 1, 2, 3. Population-based data showed hospitalization rates for hyperkalemia increased from 2.4 to 11 per thousand after widespread spironolactone use, with associated mortality rising from 0.3 to 2 per thousand 3.

Immediate Laboratory Work-Up Required:

• Serum potassium (if >5.5 mmol/L, halve spironolactone dose; if ≥6.0 mmol/L, stop immediately) 1, 2
• Serum creatinine and estimated GFR (if creatinine >220 μmol/L or 2.5 mg/dL, halve dose; if >310 μmol/L or 3.5 mg/dL, stop immediately) 1, 2
• ECG to assess for hyperkalemia-induced conduction abnormalities
• Serum sodium (spironolactone can cause hyponatremia)

Differential Diagnosis by System

1. Medication-Induced Causes (Most Likely)

Spironolactone adverse effects:

• Gastrointestinal symptoms (nausea, abdominal discomfort) are common non-serious complaints 4
• Dizziness from orthostatic hypotension or electrolyte disturbance
• Hyperkalemia presenting with weakness, dizziness, cardiac arrhythmia 1, 2, 3
• Hyponatremia (monitor if <125 mmol/L) 5

Betahistine:

• Generally well-tolerated with mild GI side effects (nausea, abdominal pain) 4
• Rarely causes significant adverse effects
• Does NOT improve dizziness outcomes beyond repositioning maneuvers in BPPV 6, 7

Apixaban:

• Can cause dizziness and GI symptoms 8
• Bleeding risk (check for occult GI bleeding if symptoms persist)
• Drug interactions with NSAIDs increase bleeding risk 8

2. Cardiovascular Causes

• Arrhythmia (atrial fibrillation with rapid ventricular response, or hyperkalemia-induced)
• Orthostatic hypotension (common with spironolactone in elderly)
• Check orthostatic vital signs: BP and pulse supine, then after 1 and 3 minutes standing

3. Gastrointestinal Causes

The combination of epigastric irritation, burping, and gas suggests:

• GERD/gastritis/peptic ulcer disease 9
• Medication-induced gastritis (spironolactone, apixaban)
• Consider upper endoscopy if symptoms persist or alarm features present (weight loss, dysphagia, hematemesis)

4. Vestibular Causes

• BPPV (betahistine prescribed suggests prior vestibular diagnosis)
• Medication-related dizziness 10 - cardiovascular and CNS agents are highly associated with dizziness in elderly

Recommended Management Algorithm

Step 1: Urgent Assessment (Same Day)

1. Vital signs including orthostatics
2. ECG
3. Stat labs: potassium, creatinine, sodium, CBC
4. Review medication timing - did symptoms start after recent dose increase?

Step 2: Based on Potassium Level

If K+ >5.5 mmol/L:

• Halve spironolactone dose (e.g., 25 mg to 12.5 mg daily or alternate days) 1, 2
• Recheck electrolytes in 3 days, then 1 week 1, 2
• Stop any potassium supplements
• Avoid NSAIDs 3, 11

If K+ ≥6.0 mmol/L:

• Stop spironolactone immediately 1, 2
• Treat hyperkalemia per protocol
• Monitor closely; may need hospitalization

If K+ normal but creatinine elevated:

• Assess for dehydration (diarrhea, reduced intake)
• Consider dose reduction if GFR <50 mL/min 3

Step 3: Address Gastrointestinal Symptoms

• Trial of PPI (omeprazole 20 mg daily) for 2 weeks for presumed GERD/gastritis
• Dietary modifications: avoid large meals, fatty foods, caffeine
• If no improvement or alarm features: upper endoscopy 9

Step 4: Reassess Betahistine Necessity

• Betahistine has minimal evidence for efficacy in BPPV beyond placebo 6, 7
• Consider discontinuation if prescribed for BPPV
• If prescribed for Ménière's disease, continue but recognize GI side effects possible 4

Step 5: Monitor Apixaban Safety

• Ensure appropriate dosing (2.5 mg BID if ≥2 of: age ≥80, weight ≤60 kg, creatinine ≥1.5 mg/dL) 12
• Check for signs of bleeding (melena, hematochezia, hematemesis)
• Avoid NSAIDs which increase bleeding risk 8

Common Pitfalls to Avoid

1. Underestimating hyperkalemia risk in elderly - serum creatinine underestimates renal dysfunction in elderly with low muscle mass; calculate actual creatinine clearance 3

2. Continuing spironolactone during acute illness - dehydration from gastroenteritis dramatically increases hyperkalemia risk 3

3. Polypharmacy interactions - spironolactone with apixaban increases bleeding risk if hyperkalemia develops; NSAIDs contraindicated 3, 11

4. Assuming betahistine is helping - no evidence it improves outcomes in BPPV; consider discontinuation 6, 7

5. Missing orthostatic hypotension - must check standing BP in elderly on diuretics

Follow-Up Monitoring

If continuing spironolactone after dose adjustment:

• Recheck K+ and creatinine at 3 days, 1 week, then monthly for 3 months 1, 2, 3
• Educate patient to report diarrhea, vomiting, or reduced oral intake immediately 3
• Avoid potassium-rich foods and salt substitutes (contain potassium)